Wednesday, May 17, 2017

Diabetes Drug Gets FDA Warning Due to Amputation Risk

Canagliflozin tied to a doubling of amputations of legs, feet, agency says Diabetes Drug Gets FDA Warning Due to Amputation Risk
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)